Protective Effects on Myelosuppression Mice Treated by Three Different Classic Chinese Medicine Formulae

Overview

Journal Pharmacogn Mag

Publisher Sage Publications

Date 2011 Jul 1

PMID 21716623

Citations 6

Authors

An-Bin Zhao

Bin Yu

Xian-Lin Wu

Ke-Jian Cao

En-Qing Li

Qing-Mei Li

Xiao-Yin Chen

Affiliations

Soon will be listed here.

Abstract

Background: In order to observe the protective therapeutic action and mechanism of Liuwei Dihuang Decoction, Buzhong Yiqi Decoction, and Compound Danshen Decoction on Myelosuppression induced by cyclophosphamide.

Materials And Methods: The mice model was established by intraperitoneal injected with 100 mg/kg cyclophosphamide by human and mice dose conversion on the 9(th), 11(th), 13(th) days during the experiment. Flow cytometry (FCM) was used for detecting the number of cells and investigating bone marrow cell cycles. Spleen was taken out and the mRNA expression level of thrombopoietin (TPO) and c-Mpl were detected by Q-PCR, and c-Mpl in spleen in order to discuss the mechanism of myelosuppression and the protective effects of traditional Chinese medicine.

Results: Both Liuwei Dihuang Decoction Group and Buzhong Yiqi Decoction Group can accelerate bone marrow hematopoietic stem progenitor cells (HSPCs) in marrow-suppressed mice and enhance cell proliferation by promoting cell cycles from G0/G1 phase to access into S, G2/M phase. And at the same time these Chinese decoctions can increase the mRNA expression level of TPO and c-Mpl in spleen.

Conclusion: Researched showed that Chinese formula take effect by affecting these genes on myelosuppressed mice.

Citing Articles

The Involvement of Macrophage Colony Stimulating Factor on Protein Hydrolysate Injection Mediated Hematopoietic Function Improvement.

Wang S, Zhang Y, Meng W, Dong Y, Zhang S, Teng L Cells. 2021; 10(10).

PMID: 34685756 PMC: 8534652. DOI: 10.3390/cells10102776.

Compatibility effects of ginseng and Ait herb pair on hematopoietic recovery in mice with cyclophosphamide-induced myelosuppression and its material basis.

Han J, Dai M, Zhao Y, Cai E, Zhang L, Jia X J Ginseng Res. 2020; 44(2):291-299.

PMID: 32148411 PMC: 7031745. DOI: 10.1016/j.jgr.2019.01.001.

The effect of Bu Zhong Yi Qi decoction on simulated weightlessness‑induced muscle atrophy and its mechanisms.

Zhu M, Liu Z, Gao M, Zhang Y, Li Y, Ling S Mol Med Rep. 2017; 16(4):5165-5174.

PMID: 28849026 PMC: 5647051. DOI: 10.3892/mmr.2017.7287.

Effects of Traditional Chinese Medicine on Chemotherapy-Induced Myelosuppression and Febrile Neutropenia in Breast Cancer Patients.

Tian H, Qin W, Wu W, Guo P, Lu Y, Liu P Evid Based Complement Alternat Med. 2015; 2015:736197.

PMID: 26347793 PMC: 4549530. DOI: 10.1155/2015/736197.

Optimization of the extraction process for the seven bioactive compounds in Yukmijihwang-tang, an herbal formula, using response surface methodology.

Kim J, Shin H, Seo C Pharmacogn Mag. 2014; 10(Suppl 3):S606-13.

PMID: 25298681 PMC: 4189279. DOI: 10.4103/0973-1296.139798.

References

Albitar M, Manshouri T, Kantarjian H, Keating M, Estrov Z, Faber J . Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia. Leuk Res. 1999; 23(1):63-9. DOI: 10.1016/s0145-2126(98)00132-5. View

Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I . Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991; 325(3):164-70. DOI: 10.1056/NEJM199107183250305. View

Methia N, Louache F, Vainchenker W, Wendling F . Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 1993; 82(5):1395-401. View

Nemunaitis J, Rabinowe S, Singer J, Bierman P, Vose J, Freedman A . Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med. 1991; 324(25):1773-8. DOI: 10.1056/NEJM199106203242504. View

Noda I, Fujieda S, Ohtsubo T, Tsuzuki H, Tanaka N, SUNAGA H . Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines. Int J Cancer. 1999; 80(1):78-84. DOI: 10.1002/(sici)1097-0215(19990105)80:1<78::aid-ijc16>3.0.co;2-s. View

Hirai H, Shimazaki C, Yamagata N, Goto H, Inaba T, Kikuta T . Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia. Eur J Haematol. 1997; 59(1):38-46. DOI: 10.1111/j.1600-0609.1997.tb00957.x. View

Tsuruta N, Yatsunami J, Takayama K, Nakanishi Y, Ichinose Y, Hara N . Granulocyte-macrophage-colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma. Cancer. 1998; 82(11):2173-83. View

Farese A, Hunt P, Boone T, MacVittie T . Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood. 1995; 86(1):54-9. View

Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A . c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001; 97(1):139-46. DOI: 10.1182/blood.v97.1.139. View

10.

Wagemaker G, Neelis K, Hartong SCC , Wognum A, Thomas G, Fielder P . The efficacy of recombinant TPO in murine And nonhuman primate models for myelosuppression and stem cell transplantation. Stem Cells. 2000; 16 Suppl 2:127-41. DOI: 10.1002/stem.5530160716. View

11.

Gurney A, de Sauvage F, Moore M . Thrombocytopenia in c-mpl-deficient mice. Science. 1994; 265(5177):1445-7. DOI: 10.1126/science.8073287. View

12.

Neelis K, Dubbelman Y, Qingliang L, Thomas G, Eaton D, Wagemaker G . Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp Hematol. 1997; 25(10):1084-93. View

13.

de Sauvage F, Luoh S, Ryan A, Dowd M, Eaton D, Moore M . Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996; 183(2):651-6. PMC: 2192470. DOI: 10.1084/jem.183.2.651. View

14.

Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, GOOD R . Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A. 1999; 96(6):3132-6. PMC: 15907. DOI: 10.1073/pnas.96.6.3132. View

15.

Zhu X, Zhu B . [Effect of AMI on proliferative cycle phase of bone marrow cells in mice]. Zhong Yao Cai. 2003; 23(10):625-7. View

16.

Neelis K, Qingliang L, Thomas G, Cohen B, Eaton D, Wagemaker G . Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion. Blood. 1997; 90(1):58-63. View